| Date | Time | Source | Announcement |
|---|---|---|---|
| 14 May 2021 | 07:00 AM | First Day of Dealings |
Cizzle Biotechnology Holdings engages in developing a blood test for the early detection of various forms of lung cancer. It develops CIZ1B protein gene and its potential as a diagnostic biomarker for detection and management of lung cancer.
CIZ share price listed at 9p in 2021.